Clonidine (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Clonidine drug offered from Mylan Pharmaceuticals Inc.. This Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | clonidine |
SUBSTANCE NAME: | CLONIDINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
ROUTE: | TRANSDERMAL |
DOSAGE FORM: | PATCH |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-02-08 |
END MARKETING DATE: | 0000-00-00 |
Clonidine HUMAN PRESCRIPTION DRUG Details:
Item Description | Clonidine from Mylan Pharmaceuticals Inc. |
LABELER NAME: | Mylan Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.1(mg/d) |
START MARKETING DATE: | 2013-02-08 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0378-0871_017e8de4-474d-42cb-b8ef-a6b1577ae995 |
PRODUCT NDC: | 0378-0871 |
APPLICATION NUMBER: | ANDA076166 |
Other CLONIDINE Pharmaceutical Manufacturers / Labelers: